{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:34:41Z","timestamp":1792521281409,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.clinthera.2011.10.014","type":"journal-article","created":{"date-parts":[[2011,11,12]],"date-time":"2011-11-12T04:58:27Z","timestamp":1321073907000},"page":"1932-1942","source":"Crossref","is-referenced-by-count":62,"title":["Effects of Acarbose Versus Glibenclamide on Glycemic Excursion and Oxidative Stress in Type 2 Diabetic Patients Inadequately Controlled by Metformin: A 24-Week, Randomized, Open-Label, Parallel-Group Comparison"],"prefix":"10.1016","volume":"33","clinical-trial-number":[{"clinical-trial-number":"nct00417729","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jun-Sing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Dou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jane","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Li","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Te","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Te","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Hsien","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne Huey-Herng","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.10.014_bib1","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2011.10.014_bib2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2011.10.014_bib3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/diacare.26.3.881","article-title":"Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c","volume":"26","author":"Monnier","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2011.10.014_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/dmrr.1149","article-title":"Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring","volume":"27","author":"Wang","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.clinthera.2011.10.014_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00125-004-1334-6","article-title":"Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin","volume":"47","author":"Nakagami","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinthera.2011.10.014_bib6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1210\/jc.2005-1005","article-title":"Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study","volume":"91","author":"Cavalot","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2011.10.014_bib7","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2337\/db08-0063","article-title":"Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients","volume":"57","author":"Ceriello","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2011.10.014_bib8","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2011.10.014_bib9","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2337\/diab.19.9.644","article-title":"Mean amplitude of glycemic excursions, a measure of diabetic instability","volume":"19","author":"Service","year":"1970","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2011.10.014_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/dmrr.962","article-title":"Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept","volume":"25","author":"Monnier","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.clinthera.2011.10.014_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0195-668X(03)00468-8","article-title":"Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies","volume":"25","author":"Hanefeld","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2011.10.014_bib12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-2006-950397","article-title":"Oxidative stress in young Zucker rats with impaired glucose tolerance is diminished by acarbose","volume":"38","author":"R\u00f6sen","year":"2006","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.clinthera.2011.10.014_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2011.10.014_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2710.2004.00599.x","article-title":"Rational pharmacotherapy in the diabetic hypertension: analysis-prescribing patterns in a general hospital in Taiwan","volume":"29","author":"Cheng","year":"2004","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.clinthera.2011.10.014_bib15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/01.CIR.0000116761.93647.30","article-title":"Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study","volume":"109","author":"Schwedhelm","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2011.10.014_bib16","first-page":"751","article-title":"The MiniMed Continuous Glucose Monitoring System (CGMS)","volume":"12","author":"Mastrototaro","year":"1999","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2011.10.014_bib17","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2337\/dc08-0075","article-title":"Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy","volume":"31","author":"Chen","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2011.10.014_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinthera.2011.10.014_bib19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.clinbiochem.2007.05.017","article-title":"Hyperhomocysteinemia and elevated ox-LDL in Tunisian type 2 diabetic patients: role of genetic and dietary factors","volume":"40","author":"Koubaa","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinthera.2011.10.014_bib20","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.clinbiochem.2008.03.003","article-title":"Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: relationship to glucose metabolism and biomarkers of insulin resistance","volume":"41","author":"Fujinami","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinthera.2011.10.014_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/dc06-1362","article-title":"Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays","volume":"30","author":"Bl\u00fcher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2011.10.014_bib22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1056-8727(02)00184-8","article-title":"Simvastatin reduces plasma concentration of high-sensitivity C-reactive protein in type 2 diabetic patients with hyperlipidemia","volume":"16","author":"Lee","year":"2002","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.clinthera.2011.10.014_bib23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.ATV.0000058402.34138.11","article-title":"Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study","volume":"23","author":"Keaney","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinthera.2011.10.014_bib24","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00125-009-1574-6","article-title":"Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy","volume":"53","author":"Monnier","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinthera.2011.10.014_bib25","series-title":"Practical Statistics for Medical Research","author":"Altman","year":"1991"},{"key":"10.1016\/j.clinthera.2011.10.014_bib26","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jama.2010.405","article-title":"Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes","volume":"303","author":"Phung","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2011.10.014_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1463-1326.2003.00239.x","article-title":"Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients","volume":"5","author":"Fischer","year":"2003","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2011.10.014_bib28","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2337\/dc08-1956","article-title":"Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents","volume":"32","author":"Kohnert","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2011.10.014_bib29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/dmrr.994","article-title":"Blood lipid levels in relation to glucose status in seven populations of Asian origin without a prior history of diabetes: the DECODA study","volume":"25","author":"Zhang","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.clinthera.2011.10.014_bib30","first-page":"152","article-title":"Effect of acarbose on glycemic control, serum lipids and lipoproteins in type 2 diabetes","volume":"50","author":"Mughal","year":"2000","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.clinthera.2011.10.014_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1507\/endocrj.K07E-107","article-title":"Acarbose treatment increases serum total adiponectin levels in patients with type 2 diabetes","volume":"55","author":"Ochiai","year":"2008","journal-title":"Endocr J"},{"key":"10.1016\/j.clinthera.2011.10.014_bib32","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.metabol.2009.04.042","article-title":"Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus","volume":"58","author":"Ozeki","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.clinthera.2011.10.014_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1677\/JME-09-0088","article-title":"Intermittent high glucose exacerbates the aberrant production of adiponectin and resistin through mitochondrial superoxide overproduction in adipocytes","volume":"44","author":"Sun","year":"2010","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.clinthera.2011.10.014_bib34","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jc.86.5.1930","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2011.10.014_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1054\/plef.1999.0091","article-title":"F2-isoprostane excretion rate and diurnal variation in human urine","volume":"61","author":"Helmersson","year":"1999","journal-title":"Prostaglandins Leukot Essent Fatty Acids"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811006953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811006953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T16:54:42Z","timestamp":1543424082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811006953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0149291811006953"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.10.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}